Thermo Fisher 1Q Net, Revenue Up, Costs Stable

Dow Jones
2025/04/23
 

By Rob Curran

 

Thermo Fisher Scientific posted 14% net-income growth in the first quarter as revenue inched up and costs remained stable.

The Waltham, Mass., maker of microscopes and other life-sciences and laboratory equipment said earnings rose to $1.51 billion, or $3.98 a share, from $1.33 billion, or $3.46 a share, a year earlier.

Excluding certain one-off items, Thermo posted adjusted earnings of $5.15 a share, topping the average Wall Street peg of $5.10 a share, according to FactSet.

Revenue rose 0.2% to $10.36 billion, ahead of the average analyst estimate of $10.23 billion. Cost of revenue rose slightly to $6.06 billion, but was stable, at 58.4%, as a percentage of revenue.

Manufacturers are monitoring tariff negotiations because of the implications for costs.

In a statement, Chairman, President and Chief Executive Marc Casper expressed confidence in the company's ability to "manage the current environment."

 

Write to Rob Curran at rob.curran@dowjones.com

 

(END) Dow Jones Newswires

April 23, 2025 06:18 ET (10:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10